Search research articles
Contact Us
Filters
Showing results (151-160 of 247) with videos related to
Page
of 25
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 30, 2025
Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients
Maria Giovanna Trivieri, Ana Devesa, Philip M Robson, et al.
European Urology
|
December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
Matthew D Galsky, Huan Wang, Noah M Hahn, et al.
Cancer Research Communications
|
June 27, 2024
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
Edgar Gonzalez-Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, et al.
Immunity
|
February 24, 2023
Monocytes re-enter the bone marrow during fasting and alter the host response to infection
Henrike Janssen, Florian Kahles, Dan Liu, et al.
Nature Medicine
|
October 9, 2019
Single-cell immune landscape of human atherosclerotic plaques
Dawn M Fernandez, Adeeb H Rahman, Nicolas F Fernandez, et al.
Research Square
|
January 10, 2024
Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant Recipients
Charles Langelier, Harry Pickering, Joanna Schaenman, et al.
Blood
|
May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies
Lucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2026
Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trial
Ziao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC
Bita Sahaf, Mina Pichavant, Brian H Lee, et al.
Cell
|
May 6, 2017
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin, Soma Kobayashi, Andrew Leader, et al.
Page
of 25
Search research articles
Search
Showing results (151-160 of 247) with videos related to
Sort By:
Page
of 25
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 30, 2025
Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients
Maria Giovanna Trivieri, Ana Devesa, Philip M Robson, et al.
European Urology
|
December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
Matthew D Galsky, Huan Wang, Noah M Hahn, et al.
Cancer Research Communications
|
June 27, 2024
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
Edgar Gonzalez-Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, et al.
Immunity
|
February 24, 2023
Monocytes re-enter the bone marrow during fasting and alter the host response to infection
Henrike Janssen, Florian Kahles, Dan Liu, et al.
Nature Medicine
|
October 9, 2019
Single-cell immune landscape of human atherosclerotic plaques
Dawn M Fernandez, Adeeb H Rahman, Nicolas F Fernandez, et al.
Research Square
|
January 10, 2024
Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant Recipients
Charles Langelier, Harry Pickering, Joanna Schaenman, et al.
Blood
|
May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies
Lucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2026
Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trial
Ziao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC
Bita Sahaf, Mina Pichavant, Brian H Lee, et al.
Cell
|
May 6, 2017
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin, Soma Kobayashi, Andrew Leader, et al.
Page
of 25